Cite

HARVARD Citation

    Morel, P. et al. (2022). Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?. Rheumatology. pp. 4056-4064. [Online]. 
  
Back to record